Beam is a pioneer of the base-editing approach to gene-editing, which can be used to convert one nucleotide base into another without cutting both strands of DNA, unlike other technologies like ...

Unlike traditional fiber lasers that produce static beams, DBL enables real-time beam shape adjustments to suit specific ...

I was looking forward to seeing how Beam Therapeutics would do in their clinical trials of single-base DNA editing therapies, and this morning we have a readout. It was a very small trial ...

The Cambridge-based base editing company, Beam Therapeutics, has announced initial safety and efficacy data from its Phase I/II trial of BEAM-302, establishing clinical proof-of-concept as a ...

Beam’s therapy employs base editing to perform an in vivo correction of the mutation at the root of the inherited disease. The Phase 1/2 test is designed with two parts: Part A is assessing the ...